Back
Eton Pharmaceuticals 10K Form
Buy
61
ETON
Eton Pharmaceuticals
Last Price:
8.52
Seasonality Move:
9.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ETON News And Ratings
See the #1 stock for the next 7 days that we like better than ETON
ETON Financial Statistics
Sales & Book Value
| Annual Sales: | $31.64M |
|---|---|
| Cash Flow: | $1.26M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.52 |
| Price / Book: | 16.16 |
Profitability
| EPS (TTM): | -0.26000 |
|---|---|
| Net Income (TTM): | $-6.69M |
| Gross Margin: | $21.06M |
| Return on Equity: | -42.84% |
| Return on Assets: | -21.32% |
Eton Pharmaceuticals Earnings Forecast
Key Eton Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 6 years for ETON is 66.56%.
- The Selling, General & Administrative Expenses for ETON have been equal to 59.83% of Gross Profit Margin.
- The Research & Development expenses have been 10.50% of Revenue.
- The Net Earning history of ETON is -2.96% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 3 years.
Eton Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ETON |
| CUSIP: | 29772L |
| Website: | etonpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.35 |
|---|---|
| Current Ratio: | 1.4 |
| Quick Ratio: | 1.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 15.89 |
ETON Technical Analysis vs Fundamental Analysis
Buy
61
Eton Pharmaceuticals (ETON)
is a Buy
Is Eton Pharmaceuticals a Buy or a Sell?
-
Eton Pharmaceuticals stock is rated a Buy
The current Eton Pharmaceuticals [ETON] share price is $8.67. The Score for ETON is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.